Brentuximab vedotinBrentuximab vedotin, sold under the brand name Adcetris, is an antibody-drug conjugate medication used to treat relapsed or refractory Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (ALCL), a type of T cell non-Hodgkin lymphoma. Read from the Drugbox of the Wikipedia article Brentuximab vedotin, revision 1370568627.

Property

Value

Formula

C6680H10245N1723O2255S40, 152052.87 g/mol

The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.